首页> 外国专利> APPLICATION OF TOPIRAMATE OR DERIVATIVES THEREOF FOR PREPARING MEDICAMENT FOR TREATING MANIACAL-DEPRESSIVE BIPOLAR STATES

APPLICATION OF TOPIRAMATE OR DERIVATIVES THEREOF FOR PREPARING MEDICAMENT FOR TREATING MANIACAL-DEPRESSIVE BIPOLAR STATES

机译:上端或下端的派生方法在制备治疗躁郁型双极性状态的药物中的应用

摘要

In the present invention, there is disclosed the use of sulfamate compounds of the general formula I, in which X represents the group CHi2 or an oxygen atom; Ri1 denotes a hydrogen atom or an alkyl group containing 1 to 4 carbon atoms; and Ri2, Ri3, Ri4, Ri5 represent independently on each other a hydrogen atom or a lower alkyl group having 1 to 3 carbon atoms and when X is oxygen atom, Ri2 and Ri3 and/or Ri4 and Ri5 together may be a methylenedioxy group of the general formula II, in which Ri6 and Ri7 are the same or different and represent a hydrogen atom, a lower alkyl group having 1 to 3 carbon atoms or Ri6 and Ri7 denote alkyl groups that are joined to form a cyclopentyl or cyclohexyl rings, wherein the compound of the general formula I is particularly topiramate, for preparing a medicament intended for the treatment of manic-depressive bipolar disorders in mammals.
机译:在本发明中,公开了通式I的氨基磺酸酯化合物的用途,其中X代表基团CH 12或氧原子。 Ri 1表示氢原子或碳原子数1〜4的烷基。和Ri2,Ri3,Ri4,Ri5彼此独立地表示氢原子或具有1至3个碳原子的低级烷基,并且当X为氧原子时,Ri2和Ri3和/或Ri4和Ri5一起可以是亚甲基二氧基。通式II,其中Ri6和Ri7相同或不同并且代表氢原子,具有1-3个碳原子的低级烷基或Ri6和Ri7表示被连接形成环戊基或环己基环的烷基,其中通式I的化合物特别是托吡酯,用于制备用于治疗哺乳动物的躁狂抑郁性双相情感障碍的药物。

著录项

  • 公开/公告号CZ9804277A3

    专利类型

  • 公开/公告日1999-08-11

    原文格式PDF

  • 申请/专利权人 ORTHO-MCNEIL PHARMACEUTICAL;

    申请/专利号CZ19980004277

  • 发明设计人 SHANK RICHARD P.;

    申请日1997-06-24

  • 分类号A61K31/18;A61K31/35;

  • 国家 CZ

  • 入库时间 2022-08-22 02:27:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号